Skip to main content

TableĀ 1 Current and future technology for staging primary cervical cancers. MRI magnetic resonance imaging, 18 FDG 18F-fluorodeoxyglucose, PET positron emission tomography, CT computed tomography, SNB sentinel node biopsy, 60 Cu-ATSM 60Cu-diacetyl-bis (N4-metylthiosemicarbazone), 18 F-FMISO 18F-fluoromisonidazole, USPIO MRI ultra small paramagnetic iron oxide-enhanced magnetic resonance imaging

From: Whole-body 18FDG PET plus pelvic MRI in the pre-treatment assessment of cervical cancers: an alternative to the FIGO clinical staging

TNM Staging T staging N staging M staging
Recommended MRI 18FDG PET 18FDG PET
Perspectives 18FDG PET-CT 18FDG PET-CT 18FDG PET-CT
Research 60Cu-ATSM PET USPIO MRI Whole-body MRI